Market Research Logo

Global Respiratory Inhalers Market, by Product Type, Application, Technology, and Region - Trends and Analysis to 2025

Global Respiratory Inhalers Market, by Product Type, Application, Technology, and Region - Trends and Analysis to 2025

Chronic respiratory diseases are the group of chronic diseases which affect airways, lungs and the other parts of respiratory system. Chronic respiratory disease include asthma and respiratory allergies, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases, Sleep Apnea Syndrome and Pulmonary Hypertension. However 70% chronic respiratory disease are asthma and chronic obstructive pulmonary disease. In 2012, globally, 1 billion people are affected with chronic respiratory disease and account for 7% of all global deaths with addition 1.4 million lung cancer deaths annually. Tuberculosis is considered as one of the communicable lung disease and in 2012, 1.3 million people died of tuberculosis and 8.6 million new cases were yet to be treated.
The respiratory inhalers market is expected to gain steady traction in the foreseeable future as the product is available in various designs and can be used by any age group individual. Manufacturers are focused on reducing production costs and increasing profitability to sustain the market demand.
Market Dynamics
Factors such as rising prevalence of asthma, chronic obstructive respiratory disease and other respiratory diseases propel the respiratory inhalers market globally. However, drawbacks such as lack of a single effective inhaler devices, adverse effects and difficulties faced during drug inhalation, lack of skilled pulmonologist, higher price of inhaler devices are factors hindering respiratory inhalers market growth.
People suffering from respiratory disorders are now switching towards combinational therapies which is associated with benefits such as increased efficacy and easy reimbursement policies. Opting for combination therapies becomes tough for the individuals who have complex indications of respiratory disease. High preference of combination therapies such as triple combination therapy for chronic obstructive pulmonary disease (COPD) patients is expected to drive growth of the global respiratory inhaler market over the forecast period.
Key features of the study:

This report provides in-depth analysis of the respiratory inhalers and is its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global respiratory inhalers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
The global respiratory inhalers market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for respiratory inhalers, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the respiratory inhalers market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Respiratory Inhalers Market, By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

Global Respiratory Inhalers Market, By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

Global Respiratory Inhalers Market, By Technology:

Digital
Manual

Global Respiratory Inhalers Market, By Geography:

North America,

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

U.S.
Canada

Europe

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

U.K.
Germany
Italy
France
Russia
Spain
Rest of Europe

Asia Pacific

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

Brazil
Mexico
Rest of Latin America

Middle East

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Dry Powder Inhalers

Single Unit Dose
Multi Dose
Multi-Unit Dose

Metered Dose Inhalers
Nebulizers

Compressed
Mesh
Ultrasonic

By Application:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Cystic Fibrosis

By Technology

Digital
Manual

By Country

North Africa
Central Africa
South Africa

Company Profiles

AstraZeneca Plc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Beximco Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Cipla Ltd.
GlaxoSmithKline Plc.
Koninklijke Philips N.V.
Merck & Co. Inc.
Omron Healthcare Europe B.V.
PARI Medical Holding
Teva Pharmaceutical Industries Ltd.
H&T PRESSPART

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Devices
Market Snippet By Technology
Market Snippet By Therapeutic Application
Market Snippet By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Challenges
Market Opportunities
Regulatory Scenario
Industry Trend
Epidemiology
Merger and Acquisitions
New Product Approvals/Launch
Promotion and Marketing Initiatives
4. Global Respiratory Inhalers Market, By Devices, 2015 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Nebulizers
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Compressed
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Mesh
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Ultrasonic
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Dry Powder Inhaler
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Single Unit Dose Inhaler
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Multi Dose Inhaler
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Multi-Unit Dose Inhaler
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Metered Dose Inhaler
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
5. Global Respiratory Inhalers Market, By Technology, 2015 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Digital
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Manual
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
6. Global Respiratory Inhalers Market, By Therapeutic Application, 2015 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Asthma
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Chronic Obstructive Pulmonary Disease
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Pulmonary Arterial Hypertension
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Cystic Fibrosis
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
7. Global Respiratory Inhalers Market, By Regions, 2015 - 2025 (US$ Million)
Introduction
Market Share Analysis, By Region, 2017 and 2025 (%)
Y-O-Y Growth Analysis, For Regions, 2015 - 2025
North America
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
U.S.
Europe
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
U.K.
Germany
Italy
France
Russia
Rest of Europe
Asia Pacific
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
Brazil
Mexico
Rest of Latin America
Middle East
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
GCC Countries
Israel
Rest of Middle East
Africa
Regional Trends
Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
Northern Africa
Central Africa
South Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
AstraZeneca plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Beximco Pharmaceuticals Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Boehringer Ingelheim GmbH
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Cipla Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
GlaxoSmithKline plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Koninklijke Philips N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
OMRON Healthcare Europe B.V.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
PARI Medical Holding
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Teva Pharmaceutical Industries Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
H&T PRESSPART
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 25 market data tables and 35 figures on "Respiratory Inhalers Market - Global forecast to 2025”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report